Stakeholder Opinions: Sexually Transmitted Diseases - An Underestimated Threat Lacking Interventions to Prevent Transmission
- Published: August 2010
- Your are here:
- Home
- Categories
- Pharmaceuticals and Healthcare
- Pharmaceuticals
Competitor Analysis: Herpes Virus Vaccines and Therapeutics
Competitor Analysis: Herpes Virus Vaccines and Therapeutics
- Published: December 2012
- Region: World
- 56 Pages
- La Merie Publishing
FEATURED COMPANIES
- Agenus AiCuris AlphaVax
- Bio Products Laboratory
- CSL Behring
- Green Cross
- Mylan
- Piramal Life Sciences
- MORE
Product description
The present Competitive Intelligence Report about Herpes Virus Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies and small molecules against infection caused by herpes simplex virus (HSV) type 1 and/or type 2 and varicella zoster virus (VZV) or human herpes virus type 3 (HHV-3) as of December 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as Human herpes virus 1 and 2 (HHV-1 and -2), are two members of the herpes virus family that infect humans. HSV-1 and HSV-2 cause the viral disease herpes simplex which can be categorized into one of several distinct disorders based on the site of infection: oral herpes with the visible symptoms of cold sores or fever blisters, genital herpes and other forms including ocular herpes (keratitis).
Varicella zoster virus (VZV) is another
READ MORE >
- Varicella zoster virus (VZV) Vaccines
- Herpes Simplex Virus (HSV) type 1/2 Vaccines
- HSV Antibodies
- HSV Small Molecules
- Herpetic Keratitis
- Corporate Herpes Virus Vaccine & Therapeutic R&D Pipelines
- Agenus AiCuris AlphaVax
- Anhui Anke Biotechnology
- aRigen Pharmaceuticals
- Asahi Kasei Pharma
- ausch + Lomb
- Beech Tree Labs
- BIKEN
- Bio Products Laboratory
- BioAlliance Pharma
- Biotest
- BTA Pharmaceuticals
- Cangene
- Changchun Institute of Biological Products
- Chimerix
- Coridon
- CSL Behring
- CSL Biotherapies
- Development Center for Biotechnology
- Epiphany Biosciences
- Functional Genetics
- Genocea Biosciences
- GenVec
- GlaxoSmithKline
- Green Cross
- Immune Design
- Lumavita
- Medivir
- Meda
- Menarini
- Merck & Co
- Mylan
- Mymetics
- NanoBio
- NanoViricides
- New American Therapeutics
- NIAID
- Novartis
- Piramal Life Sciences
- Resolvyx Pharmaceuticals
- Roxane Laboratories
- Sanofi Pasteur
- Shanghai Institute of Biological Products
- Shenzhen Neptunus Interlong Biotechnique Company
- Sinovac Biotech
- Southern Illinolis School of Medicine
- Starpharma
- Synergy Pharmaceuticals
- Teva Pharmaceutical Industries
- Trigon Biotechnological
- Valeant Pharmaceuticals
- Vical
- Watson Pharmaceuticals
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
| Site License | The report will be emailed to you. The report is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |
Note: Product cover images may vary from those shown
RELATED PRODUCTS
-
Stakeholder Opinions: Sexually Transmitted Diseases - An Underestimated Threat Lacking Interventions to Prevent Transmission
FROM -
Global Herpes Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
- Published: November 2011
FROM -
Emerging Microbiology Tests and Companies Developing New Technologies and Products
- Published: February 2012
FROM -
Future Horizons in the US Microbiology Market: Supplier Shares and Sales Forecasts for 100 Infectious Disease Tests by Market Segment
Future Horizons in the US Microbiology Market: Supplier Shares and Sales Forecasts for 100 Infectious Disease Tests by Market Segment
- Language: English
- Published: August 2012
FROM -
Analysis of Emerging Nucleic Acid Testing Assays And Strategic Profiles of Leading Suppliers
- Language: English
- 549 Pages
- Published: September 2012
- Region: World
FROM -
Analysis of Emerging Molecular Diagnostics Tests And Strategic Profiles of Leading Suppliers
- Language: English
- 505 Pages
- Published: September 2012
- Region: World
FROM -
CompetitiveWatch Molecular Diagnostics: Strategic Assessments of Major Suppliers
- Language: English
- 120 Pages
- Published: May 2013
- Region: World
FROM -
CompetitiveWatch Nucleic Acid Testing: Strategic Profiles of Leading Suppliers
- Language: English
- 549 Pages
- Published: May 2013
- Region: World
FROM -
Mucocutaneous Manifestations of Viral Diseases. An Illustrated Guide to Diagnosis and Management. Edition No. 2
- Language: English
- 600 Pages
- Published: March 2010
-
Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth
- Language: English
- 124 Pages
- Published: April 2013
- Region: World
FROM
